UroLift – a new, simple way of treating an enlarged prostate

Written by: Mr Rajesh Kavia
Published:
Edited by: Jay Staniland

UroLift is a new minimally-invasive technique for treating an enlarged prostate, otherwise known as benign prostatic hyperplasia (BPH), by lifting the enlarged prostate tissue away from the urethra, so it doesn’t block it anymore. Consultant urological surgeon Mr Rajesh Kavia is one of the few surgeons in the UK able to provide this treatment.

 

Benign prostatic hyperplasia (BPH) symptoms

 

The prostate is a gland located next to the bladder and surrounds the urethra. With Benign Prostatic Hyperplasia, the prostate becomes enlarged and can restrict the urethra, making it difficult to start to pass urine, and also to completely empty the bladder. The enlarged prostate can also press on the bladder causing a frequent desire to pee.


BPH is a common condition in men over 50, however, it is not believed to be linked to prostate cancer, with men with BPH being at no greater risk of prostate cancer than those without. The cause is not known, but is believed to be related to changes in the hormonal balance as men age.

 

UroLift: a treatment for BPH

 

UroLift is a simple procedure performed by a consultant urologist where small implants are put in place in the urethra that holds the two halves of the enlarged prostate open.

 

  1. A UroLift Delivery Device, a small device used to insert implants into the prostate, is inserted into the urethra, via the penis. The correct positioning is located via the use of an endoscope in the UroLift Delivery Device.
  2. Permanent implants are inserted into the prostate gland through a small needle. These implants hold the two lobes of the prostate gland open around the urethra, allowing the patient to pass urine more easily.
  3. The UroLift introducer is removed, and the implants permanently left in place.

 

The benefits of the UroLift system

 

UroLift is a minimally invasive procedure, meaning that the recovery time is much faster for the patient. The procedure is simple, meaning there are very few possible complications. The BPH symptoms are relieved very quickly, with patients experiencing few or no symptoms from two weeks after the procedure.


The patient’s sexual function is also maintained, and no medication is needed after the procedure. Compared to the more invasive procedures, where patients have the risk of incontinence, erectile dysfunction and retrograde ejaculation.

By Mr Rajesh Kavia
Urology

Mr Rajesh Kavia is a leading London consultant urological surgeon, with a special interest in functional urology and incontinence in males and females. He treats all manner of urological problems from his private clinics across London, and was the first surgeon within the M25 to perform the Urolift procedure to treat benign prostate obstruction, using minimally invasive surgical techniques.

Mr Kavia has undertaken extensive research in a number of urological conditions, such as being the lead author on a multinational trial of cannabis for multiple sclerosis-related overactive bladder syndrome, and in painful bladder syndrome at the National Hospital for Neurology and Neurosurgery. Alongside his clinical and research work, Mr Kavia dedicates time to teaching junior doctors, and is a course director and examiner for higher surgical trainees, he has also published numerous articles in peer-reviewed medical journals.

View Profile

Overall assessment of their patients


We use cookies on this site to enhance your user experience. Click ‘Enter’ to continue browsing. Enter Cookies policy